ApicHope Pharmaceutical Co., Ltd
SZSE:300723.SZ
26.51 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 2,503.447 | 2,280.199 | 2,199.214 | 1,675.417 | 1,637.406 | 1,429.554 | 1,380.217 | 1,250.837 | 1,028.297 | 792.555 | 507.567 |
| Kosten van de omzet
| 474.581 | 300.204 | 318.462 | 295.427 | 367.03 | 393.473 | 579.91 | 599.391 | 478.768 | 391.438 | 316.614 |
| Brutowinst
| 2,028.866 | 1,979.995 | 1,880.753 | 1,379.99 | 1,270.375 | 1,036.082 | 800.308 | 651.446 | 549.53 | 401.117 | 190.953 |
| Brutowinstmarge
| 0.81 | 0.868 | 0.855 | 0.824 | 0.776 | 0.725 | 0.58 | 0.521 | 0.534 | 0.506 | 0.376 |
| Onderzoek- en ontwikkelingskosten
| 301.368 | 189.78 | 142.323 | 135.344 | 98.049 | 91.381 | 81.069 | 46.967 | 30.557 | 40.321 | 18.494 |
| Algemene en administratieve kosten
| 131.89 | 64.083 | 52.511 | 18.879 | 28.088 | 29.892 | 25.779 | 14.483 | 44.876 | 11.799 | 36.08 |
| Verkoop- en marketingkosten
| 1,123.502 | 1,248.854 | 1,281.679 | 934.458 | 851.112 | 614.077 | 439.477 | 371.633 | 328.302 | 245.882 | 100.771 |
| Verkoop-, algemene en administratieve kosten
| 1,255.393 | 1,312.936 | 1,334.191 | 953.337 | 879.199 | 643.97 | 465.255 | 386.116 | 373.178 | 257.682 | 136.85 |
| Overige kosten
| 30.255 | 31.97 | 101.449 | 74.744 | 6.79 | 8.878 | 3.348 | 22.681 | 1.634 | 2.227 | -0.376 |
| Bedrijfskosten
| 1,754.208 | 1,646.04 | 1,601.94 | 1,181.56 | 1,044.142 | 796.663 | 596.521 | 488.859 | 444.518 | 326.101 | 140.196 |
| Bedrijfsresultaat
| 213.93 | 281.974 | 285.282 | 198.554 | 182.267 | 234.83 | 181.697 | 141.801 | 80.82 | 52.858 | 43.709 |
| Bedrijfsresultaat ratio
| 0.085 | 0.124 | 0.13 | 0.119 | 0.111 | 0.164 | 0.132 | 0.113 | 0.079 | 0.067 | 0.086 |
| Totaal overige inkomsten en kosten netto
| 30.255 | 44.439 | 77.489 | 74.744 | 6.79 | 8.878 | 3.348 | 22.386 | 1.454 | 2.18 | -0.397 |
| Inkomen voor belasting
| 244.185 | 326.414 | 362.771 | 273.298 | 189.057 | 243.708 | 185.045 | 164.187 | 82.274 | 55.037 | 43.312 |
| Inkomen voor belasting ratio
| 0.098 | 0.143 | 0.165 | 0.163 | 0.115 | 0.17 | 0.134 | 0.131 | 0.08 | 0.069 | 0.085 |
| Belastingkosten
| 92.39 | 64.317 | 69.357 | 49.662 | 46.528 | 36.022 | 30.226 | 28.345 | 21.873 | 15.839 | 10.988 |
| Nettowinst
| 184.613 | 290.683 | 306.915 | 225.611 | 143.686 | 208.224 | 156.695 | 137.35 | 60.42 | 40.31 | 32.994 |
| Nettowinstmarge
| 0.074 | 0.127 | 0.14 | 0.135 | 0.088 | 0.146 | 0.114 | 0.11 | 0.059 | 0.051 | 0.065 |
| WPA (Winst Per Aandeel)
| 0.42 | 0.69 | 0.71 | 0.52 | 0.33 | 0.48 | 0.47 | 0.42 | 0.19 | 0 | 0 |
| Verwaterde WPA
| 0.42 | 0.69 | 0.71 | 0.52 | 0.33 | 0.48 | 0.47 | 0.42 | 0.19 | 0 | 0 |
| EBITDA
| 470.474 | 450.276 | 475.517 | 328.557 | 283.434 | 308.05 | 240.899 | 216.864 | 145.896 | 94.966 | 62.877 |
| EBITDA ratio
| 0.188 | 0.197 | 0.216 | 0.196 | 0.173 | 0.215 | 0.175 | 0.173 | 0.142 | 0.12 | 0.124 |